B+
Bull case
20%
Probability
Target price
$175.00
+33.7% vs current
GH
Guardant HealthBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-11
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$113.84
-13.0% vs current
B-
Bear case
20%
Probability
Target price
$55.00
-58.0% vs current
AI sentiment snapshot
Latest data as of 2026-02-20
Recent news sentiment (30D)
-29.3
Negative
Company
-
Unavailable
Macro
-29.3
Negative
Pulse
-
Unavailable
Sentiment proxy
+33.4
Score
AI commentary
Sentiment is mixed — analyst targets cluster near the median while the high/low spread is wide, reflecting disagreement on reimbursement and adoption. Near-term focus: results and payer updates; long-term view depends on commercial traction and regulatory clarity.
RankAlpha Sentiment AI - 2026-02-20
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-21catalystNext quarterly results / revenue updateHigh impact
Quarterly results may revise revenue guidance and near-term visibility; market reaction likely focused on diagnostic volumes and margin commentary.
2026-09-30eventClinical readout or regulatory decision for new indicationHigh impact
Binary clinical/regulatory outcomes may drive large re-rating; date provided as planning-window end per event-rule.
2027-02-20catalystBroader commercial adoption and payer coverageHigh impact
Expanded payer coverage and international rollout could materially lift recurring revenue over the long horizon; timing assumed per long-window rule.
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-20 • Updated nightlySource: Internal modelMethodology